Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-08 | Dr. Amy E. HerrIndependent Director | -6,64k | 4,51k | Derivative Exercise and Sale | 47,60 - 48,28 | 2,88k | - |
| 2026-05-05 | Mr. James T. HippelExec. VP of Finance & CFO | -56,96k | 517,15k | Derivative Exercise and Sale | 47,60 - 56,68 | 153,67k | - |
| 2026-05-05 | Mr. James T. HippelExec. VP of Finance & CFO | 5,05k | 240,14k | Derivative Exercise and Retained Stock | 47,60 | 153,67k | 3,39% |
| 2026-05-05 | Mr. Shane BohnenSenior VP, General Counsel, Corporate Secretary & Chief Sustainability Officer | -7,06k | 64,06k | Derivative Exercise and Sale | 47,60 - 56,68 | 7,25k | - |
| 2026-05-05 | Mr. Shane BohnenSenior VP, General Counsel, Corporate Secretary & Chief Sustainability Officer | 1,35k | 64,02k | Derivative Exercise and Retained Stock | 47,60 | 7,25k | 22,78% |
| 2026-05-05 | Mr. Kim KeldermanCEO, President & Director | -23,95k | 217,48k | Derivative Exercise and Sale | 47,60 - 56,68 | 65,80k | - |
| 2026-05-05 | Mr. Kim KeldermanCEO, President & Director | 2,74k | 130,47k | Derivative Exercise and Retained Stock | 47,60 | 65,80k | 4,35% |
| 2026-05-01 | Mr. Steven C. CrousePresident of Diagnostics and Spatial Biology Segment | -311,00 | 17,11k | Derivative Exercise and Sale | 55,02 | 6,34k | - |
| 2026-05-01 | Mr. Steven C. CrousePresident of Diagnostics and Spatial Biology Segment | 483,00 | 0,00 | Derivative Exercise and Retained Stock | - | 6,34k | 8,25% |
| 2026-04-22 | Mr. Kim KeldermanCEO, President & Director | -1,36k | 79,84k | Derivative Exercise and Sale | 58,58 | 63,06k | - |
| 2026-04-22 | Mr. Kim KeldermanCEO, President & Director | 9,98k | 0,00 | Derivative Exercise and Retained Stock | - | 63,06k | 18,80% |
| 2026-04-22 | Mr. James T. HippelExec. VP of Finance & CFO | -56,10k | 3,29M | Derivative Exercise and Sale | 58,58 | 148,63k | - |
| 2026-04-22 | Mr. James T. HippelExec. VP of Finance & CFO | 5,90k | 0,00 | Derivative Exercise and Retained Stock | - | 148,63k | 4,14% |
| 2026-04-14 | Mr. Kim KeldermanCEO, President & Director | -32,09k | 1,88M | Derivative Exercise and Sale | 58,66 | 53,08k | - |
| 2026-04-14 | Mr. Kim KeldermanCEO, President & Director | 4,41k | 0,00 | Derivative Exercise and Retained Stock | - | 53,08k | 9,07% |
| 2026-04-03 | Mr. Shane BohnenSenior VP, General Counsel, Corporate Secretary & Chief Sustainability Officer | -740,00 | 39,32k | Derivative Exercise and Sale | 53,13 | 5,90k | - |
| 2026-04-03 | Mr. Shane BohnenSenior VP, General Counsel, Corporate Secretary & Chief Sustainability Officer | 1,52k | 0,00 | Derivative Exercise and Retained Stock | - | 5,90k | 34,64% |
| 2026-02-17 | Dr. Amy E. HerrIndependent Director | -1,98k | 116,79k | Vente | 59,11 | 2,88k | -40,69% |
| 2026-02-03 | Dr. Amy E. HerrIndependent Director | 22,00 | 0,00 | Derivative Exercise and Retained Stock | - | 4,86k | 0,46% |
| 2026-02-03 | Dr. Amy E. HerrIndependent Director | -16,00 | 1,03k | Derivative Exercise and Sale | 64,63 | 4,86k | - |
| 2026-02-01 | Dr. Matthew F. McManusInitié | 2,96k | 0,00 | Derivative Exercise and Retained Stock | - | 7,69k | 62,43% |
| 2026-02-01 | Dr. Matthew F. McManusInitié | -1,67k | 106,71k | Derivative Exercise and Sale | 64,09 | 7,69k | - |
| 2025-11-03 | Mr. James T. HippelExec. VP of Finance & CFO | 12,84k | 0,00 | Derivative Exercise and Retained Stock | - | 142,72k | 9,89% |
| 2025-11-03 | Mr. James T. HippelExec. VP of Finance & CFO | -11,87k | 742,39k | Derivative Exercise and Sale | 62,57 | 142,72k | - |
| 2025-11-03 | Mr. Kim KeldermanCEO, President & Director | -2,30k | 144,10k | Sale to Issuer | 62,57 | 48,67k | -4,52% |
| 2025-11-03 | Mr. William A. GeistPresident of Protein Sciences Segment | 5,39k | 0,00 | Derivative Exercise and Retained Stock | - | 20,50k | 35,67% |
| 2025-11-03 | Mr. William A. GeistPresident of Protein Sciences Segment | -4,52k | 282,82k | Derivative Exercise and Sale | 62,57 | 20,50k | - |
| 2025-08-25 | Dr. Roeland NusseInitié | -17,04k | 588,23k | Derivative Exercise and Sale | 21,84 - 56,36 | 44,56k | - |
| 2025-08-25 | Mr. Robert V. BaumgartnerIndependent Chairman of the Board | -17,04k | 585,66k | Derivative Exercise and Sale | 21,84 - 56,21 | 44,86k | - |
| 2025-08-15 | Mr. James T. HippelExec. VP of Finance & CFO | 2,08k | 0,00 | Derivative Exercise and Retained Stock | - | 129,88k | 1,63% |
| 2025-08-15 | Mr. James T. HippelExec. VP of Finance & CFO | -1,93k | 103,23k | Derivative Exercise and Sale | 53,60 | 129,88k | - |
| 2025-08-15 | Mr. Kim KeldermanCEO, President & Director | 4,24k | 0,00 | Derivative Exercise and Retained Stock | - | 50,97k | 9,07% |
| 2025-08-15 | Mr. Kim KeldermanCEO, President & Director | -4,31k | 230,75k | Derivative Exercise and Sale | 53,60 | 50,97k | - |
| 2025-08-15 | Dr. Amy E. HerrIndependent Director | 178,00 | 0,00 | Derivative Exercise and Retained Stock | - | 3,19k | 5,90% |
| 2025-08-15 | Dr. Amy E. HerrIndependent Director | -101,00 | 5,41k | Derivative Exercise and Sale | 53,60 | 3,19k | - |
| 2025-08-15 | Mr. William A. GeistPresident of Protein Sciences Segment | 1,82k | 0,00 | Derivative Exercise and Retained Stock | - | 15,11k | 13,69% |
| 2025-08-15 | Mr. William A. GeistPresident of Protein Sciences Segment | -803,00 | 43,04k | Derivative Exercise and Sale | 53,60 | 15,11k | - |
| 2025-08-15 | Dr. Matthew F. McManusInitié | 1,76k | 0,00 | Derivative Exercise and Retained Stock | - | 4,74k | 59,00% |
| 2025-08-15 | Dr. Matthew F. McManusInitié | -880,00 | 47,17k | Derivative Exercise and Sale | 53,60 | 4,74k | - |
| 2025-08-15 | Mr. Shane BohnenSenior VP, General Counsel, Corporate Secretary & Chief Sustainability Officer | 1,19k | 0,00 | Derivative Exercise and Retained Stock | - | 4,39k | 37,29% |
| 2025-08-15 | Mr. Shane BohnenSenior VP, General Counsel, Corporate Secretary & Chief Sustainability Officer | -527,00 | 28,25k | Derivative Exercise and Sale | 53,60 | 4,39k | - |
| 2025-08-07 | Mr. John L. HigginsIndependent Director | 5,04k | 110,07k | Derivative Exercise and Retained Stock | 21,84 | 65,24k | 8,37% |
| 2025-07-29 | Mr. James T. HippelExec. VP of Finance & CFO | 21,19k | 939,31k | Derivative Exercise and Retained Stock | 44,33 | 127,80k | 19,88% |
| 2025-07-29 | Mr. James T. HippelExec. VP of Finance & CFO | -147,43k | 2,10M | Derivative Exercise and Sale | 44,33 - 58,55 | 127,80k | - |
| 2025-07-22 | Mr. Kim KeldermanCEO, President & Director | 4,53k | 200,68k | Derivative Exercise and Retained Stock | 44,33 | 46,73k | 10,73% |
| 2025-07-22 | Mr. Kim KeldermanCEO, President & Director | -43,65k | 383,67k | Derivative Exercise and Sale | 44,33 - 53,12 | 46,73k | - |
| 2025-07-15 | Mr. Kim KeldermanCEO, President & Director | 3,20k | 141,81k | Derivative Exercise and Retained Stock | 44,33 | 42,20k | 8,20% |
| 2025-07-15 | Mr. Kim KeldermanCEO, President & Director | -32,93k | 233,49k | Derivative Exercise and Sale | 44,33 - 51,42 | 42,20k | - |
| 2025-06-09 | Dr. Amy E. HerrIndependent Director | -1,28k | 6,96k | Derivative Exercise and Sale | 44,33 - 49,77 | 3,02k | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
